You can post now and register later.
If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.
By using the community in any way you agree to our Terms of Use and We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.
Question
..............................
Interesting read....
https://www.tga.gov.au/sites/default/files/guidance-use-medicinal-cannabis-treatment-multiple-sclerosis-australia.pdf
Guidance for the use of medicinal cannabis in the treatment of multiple sclerosis in Australia
Version 1, December 2017
A set of guidance documents has been made available to assist doctors and their patients
who choose to prescribe medicinal cannabis in Australia under current access schemes. These
have been developed based on reviews of available evidence for the use of medicinal cannabis
in five different settings. Included is an overview addressing the evidence base for medicinal
cannabis therapy generally as well as specific documents relating to medicinal cannabis in the
treatment of palliative care, epilepsy, chemotherapy-induced nausea and vomiting (CINV),
multiple sclerosis (MS) and chronic pain.
This document reflects the evidence supporting the use of medicinal cannabis in treating
symptoms of MS, including pain, spasticity, bladder spasm, ataxia and tremor, adverse events,
quality of life and disability and the recommendations of the Multiple Sclerosis Working Group.
Link to comment
Share on other sites
0 answers to this question
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.